Nothing Special   »   [go: up one dir, main page]

ATE316071T1 - O-anisamid-derivate - Google Patents

O-anisamid-derivate

Info

Publication number
ATE316071T1
ATE316071T1 AT00956871T AT00956871T ATE316071T1 AT E316071 T1 ATE316071 T1 AT E316071T1 AT 00956871 T AT00956871 T AT 00956871T AT 00956871 T AT00956871 T AT 00956871T AT E316071 T1 ATE316071 T1 AT E316071T1
Authority
AT
Austria
Prior art keywords
denotes
group
preparing
processes
anisamide
Prior art date
Application number
AT00956871T
Other languages
English (en)
Inventor
Hiroya Satoh
Masakatsu Komuro
Koji Murakami
Katsuya Awano
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE316071T1 publication Critical patent/ATE316071T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00956871T 1999-09-17 2000-09-01 O-anisamid-derivate ATE316071T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26307099 1999-09-17

Publications (1)

Publication Number Publication Date
ATE316071T1 true ATE316071T1 (de) 2006-02-15

Family

ID=17384431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956871T ATE316071T1 (de) 1999-09-17 2000-09-01 O-anisamid-derivate

Country Status (10)

Country Link
US (1) US6706763B1 (de)
EP (1) EP1219595B1 (de)
KR (1) KR100683435B1 (de)
CN (1) CN1186315C (de)
AT (1) ATE316071T1 (de)
AU (1) AU778282B2 (de)
CA (1) CA2385083C (de)
DE (1) DE60025621T2 (de)
HU (1) HUP0202731A3 (de)
WO (1) WO2001021578A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
US7176204B2 (en) 2000-12-05 2007-02-13 Kyorin Pahrmaceutical Co., Ltd. Substituted carboxylic acid derivatives
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
EP1375472A4 (de) 2001-03-30 2008-12-10 Eisai R&D Man Co Ltd Benzolverbindung und salz davon
JPWO2002080899A1 (ja) * 2001-03-30 2005-01-06 エーザイ株式会社 消化器疾患治療剤
TWI311133B (en) 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
RU2341513C2 (ru) * 2001-06-12 2008-12-20 Веллстат Терапьютикс Корпорейшн Соединения для лечения метаболических заболеваний
EP1452521A4 (de) 2001-08-17 2007-03-14 Eisai R&D Man Co Ltd Cyclische verbindung und ppar-agonist
CA2469882C (en) * 2001-12-11 2009-09-29 Kazuo Orita Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same
CN102875441A (zh) 2003-07-17 2013-01-16 普莱希科公司 Ppar活性化合物
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
JPWO2006016637A1 (ja) * 2004-08-11 2008-05-01 杏林製薬株式会社 新規環状アミノ安息香酸誘導体
JP2008521829A (ja) 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
US20060227421A1 (en) * 2005-04-06 2006-10-12 Stover Carl A Optical bodies including strippable boundary layers
EP1879564B1 (de) * 2005-04-07 2009-12-23 Astrum Therapeutics Pty, Ltd. Verbindungen zur behandlung von amyloidose und verhinderung des tods von beta-zellen bei diabetes mellitus typ 2
US20080249137A1 (en) * 2005-09-07 2008-10-09 Jack Lin PPAR active compounds
PE20090159A1 (es) 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
US6001862A (en) * 1995-06-02 1999-12-14 Kyorin Pharameuticals Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
JP4618845B2 (ja) * 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体

Also Published As

Publication number Publication date
DE60025621T2 (de) 2006-11-23
HUP0202731A2 (hu) 2003-02-28
WO2001021578A1 (fr) 2001-03-29
EP1219595A4 (de) 2004-08-18
US6706763B1 (en) 2004-03-16
CA2385083C (en) 2007-06-05
CA2385083A1 (en) 2001-03-29
KR20020029134A (ko) 2002-04-17
EP1219595B1 (de) 2006-01-18
HUP0202731A3 (en) 2003-10-28
CN1374940A (zh) 2002-10-16
CN1186315C (zh) 2005-01-26
KR100683435B1 (ko) 2007-02-20
AU778282B2 (en) 2004-11-25
EP1219595A1 (de) 2002-07-03
AU6867900A (en) 2001-04-24
DE60025621D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
ATE316071T1 (de) O-anisamid-derivate
DE60009929D1 (de) Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
EP1609798A4 (de) Kondensiertes heterocyclisches derivat, dieses enthaltende medizinische zusammensetzung und deren medizinische verwendung
DE60018064D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
HK1084396A1 (en) Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
EP0884326A3 (de) Antithrombotische Verbindung
NO986141D0 (no) Tetrahydrobenzindolforbindelser
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
BRPI0606501A2 (pt) derivados de ácido 3-fenilpropiÈnico, composto, composição farmacêutica que o contém, utilização do composto e método de tratamento e/ou profilaxia de enfermidades e condições mediadas por gama receptor ativado por proliferador de peroxissome (ppary)
AU2003207808A1 (en) Peroxisome proliferator activated receptor modulators
PT1179342E (pt) Composicoes medicinais de libertacao imediata para utilizacao oral
HUP0400117A2 (hu) A 2-metil-2-[4-({[4-metil-2-(4-trifluormetil-fenil)-tiazol-5-karbonil]-amino}-metil)-fenoxi]-propionsav polimorf formái, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0202701A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
MY122570A (en) Benzamide derivatives and drugs containing the same
DE60020246D1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
CA2487450A1 (en) (2s)-2-ethylphenylpropanoic acid derivatives
AU2001260695A1 (en) Malto-oligosaccharide derivatives and use thereof
NO20042881L (no) Substituerte cykloheksan-derivater
HUP0203222A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties